Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy. [electronic resource]
Producer: 20010531Description: 374-81 p. digitalISSN:- 0951-3590
- Administration, Oral
- Aged
- Amino Acids -- urine
- Biomarkers -- blood
- Bone Resorption
- Collagen -- urine
- Estrogen Replacement Therapy
- Estrogens -- administration & dosage
- Female
- Follicle Stimulating Hormone -- blood
- Humans
- Luteinizing Hormone -- blood
- Middle Aged
- Norethindrone -- administration & dosage
- Osteocalcin -- blood
- Osteogenesis -- drug effects
- Peptide Fragments -- urine
- Postmenopause
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.